郑州大学学报(医学版)
鄭州大學學報(醫學版)
정주대학학보(의학판)
JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES)
2014年
5期
636-640
,共5页
胡小宁%黄学勇%杜燕华%尤爱国%许汴利
鬍小寧%黃學勇%杜燕華%尤愛國%許汴利
호소저%황학용%두연화%우애국%허변리
发热伴血小板减少综合征布尼亚病毒%核蛋白%原核表达%抗原性
髮熱伴血小闆減少綜閤徵佈尼亞病毒%覈蛋白%原覈錶達%抗原性
발열반혈소판감소종합정포니아병독%핵단백%원핵표체%항원성
severe fever with thrombocytopenia syndrome bunyavirus%nucleocapsid protein%prokaryotic expression%antigenicity
目的:构建发热伴血小板减少综合征布尼亚病毒( SFTSV)核蛋白( NP)基因的原核表达载体,获得纯化并具有抗原性的重组表达蛋白。方法:提取病毒RNA,逆转录为cDNA后 PCR 扩增得到目的片段;通过连接pMD18-T构建克隆载体,测序正确后连接至原核表达载体pMAL-c2x中,转化大肠杆菌JM 109,IPTG诱导表达、纯化MBP-NP融合蛋白。采用SDS-PAGE、Western blot对融合蛋白进行分析;建立间接ELISA方法对SFTSV患者血清NP抗体进行检测。结果:成功构建了NP基因的原核表达载体pMAL-c2x-NP,通过优化表达条件获得了纯化的带MBP标签的融合蛋白,经免疫印迹杂交证实重组蛋白具有抗原性。用建立的ELISA方法检测96例SFTSV患者血清,阳性率为40.6%;实时荧光定量RT-PCR 方法阳性率为55.2%,两者符合率为77.1%( Kappa=0.550, P<0.001)。结论:成功构建了SFTSV NP基因的原核表达系统,诱导表达了具有抗原性的MBP-NP融合蛋白,为进一步研发SFTSV的ELISA诊断试剂盒奠定了基础。
目的:構建髮熱伴血小闆減少綜閤徵佈尼亞病毒( SFTSV)覈蛋白( NP)基因的原覈錶達載體,穫得純化併具有抗原性的重組錶達蛋白。方法:提取病毒RNA,逆轉錄為cDNA後 PCR 擴增得到目的片段;通過連接pMD18-T構建剋隆載體,測序正確後連接至原覈錶達載體pMAL-c2x中,轉化大腸桿菌JM 109,IPTG誘導錶達、純化MBP-NP融閤蛋白。採用SDS-PAGE、Western blot對融閤蛋白進行分析;建立間接ELISA方法對SFTSV患者血清NP抗體進行檢測。結果:成功構建瞭NP基因的原覈錶達載體pMAL-c2x-NP,通過優化錶達條件穫得瞭純化的帶MBP標籤的融閤蛋白,經免疫印跡雜交證實重組蛋白具有抗原性。用建立的ELISA方法檢測96例SFTSV患者血清,暘性率為40.6%;實時熒光定量RT-PCR 方法暘性率為55.2%,兩者符閤率為77.1%( Kappa=0.550, P<0.001)。結論:成功構建瞭SFTSV NP基因的原覈錶達繫統,誘導錶達瞭具有抗原性的MBP-NP融閤蛋白,為進一步研髮SFTSV的ELISA診斷試劑盒奠定瞭基礎。
목적:구건발열반혈소판감소종합정포니아병독( SFTSV)핵단백( NP)기인적원핵표체재체,획득순화병구유항원성적중조표체단백。방법:제취병독RNA,역전록위cDNA후 PCR 확증득도목적편단;통과련접pMD18-T구건극륭재체,측서정학후련접지원핵표체재체pMAL-c2x중,전화대장간균JM 109,IPTG유도표체、순화MBP-NP융합단백。채용SDS-PAGE、Western blot대융합단백진행분석;건립간접ELISA방법대SFTSV환자혈청NP항체진행검측。결과:성공구건료NP기인적원핵표체재체pMAL-c2x-NP,통과우화표체조건획득료순화적대MBP표첨적융합단백,경면역인적잡교증실중조단백구유항원성。용건립적ELISA방법검측96례SFTSV환자혈청,양성솔위40.6%;실시형광정량RT-PCR 방법양성솔위55.2%,량자부합솔위77.1%( Kappa=0.550, P<0.001)。결론:성공구건료SFTSV NP기인적원핵표체계통,유도표체료구유항원성적MBP-NP융합단백,위진일보연발SFTSV적ELISA진단시제합전정료기출。
Aim:To construct a MBP-tag prokaryotic expression plasmid containing the nucleocapsid protein ( NP) gene of severe fever with thrombocytopenia syndrome bunyavirus (SFTSV)and to obtain the purified fusion protein with antigenic activity.Methods: Total RNA from the virus was extracted to synthesize cDNA .The NP gene was cloned into a pMD 18-T cloning vector.After sequencing was confirmed ,the NP gene digested from the pMD 18-T-NP was inserted into the pMAL-c2x vector.The E.coli JM109 strain was transformed with the recombinant vector and induced to express MBP-NP fusion protein through IPTG.The production was analyzed with SDS-PAGE and Western blot.An indirect ELISA method was estab-lished to detect the NP antibody from SFTSV patients serum .Results:The recombinant expression vector pMAL-c2x-NP was constructed successfully .Moreover,the purified recombinant protein with MBP-tag was acquired with optimized induc-tion and Amylose resin .A special SFTSV antigenicity of this fusion protein was identified by western blot .The established ELISA method showed a positive rate of 406.% for 96 clinical samples .Compared with the real-time RT-PCR,the coinci-dence rate of indirect ELISA was 77.1%(Kappa=0.550,P<0.001).Conclus ion:A prokaryotic expression system con-taining the NP gene of SFTSV was constructed and the fusion protein possessing antigenicity was efficiently expressed after induction.The established indirect ELISA provided a basis for the development of ELISA kit .